Growth stage venture investment firm focused on helping entrepreneurs build mission-driven global consumer technology companies.
Business Model:
Revenue: $0
Employees: 0-0
Address: 115 Fifth Ave
City: New York
State: NY
Zip: 10003
Country: US
Blisce Advisors and Blisce US - are growth stage venture investment firms focused on helping entrepreneurs build mission-driven global consumer brands and technology companies (Early Growth - Pre-IPO). Regulatory Disclosure: The Blisce Group is an international investment management group that focuses on private equity and venture capital opportunities in technology companies and startups. The Blisce Group includes Blisce Advisors, which operates in Paris and provides direct advisory services to the Blisce Group’s clients, and Blisce US LLC, which operates in New York and focused on venture capital investment opportunities, at times on behalf of the Blisce Group. Within the Blisce Group, Charles-Henri Prevost, Alexandre Mars, Romain Sion, Romain Dovilliers, Anne-Claire Colomb, are personnel solely of Blisce Advisors, and Sam Giber &a; Himanish Shah are personnel solely of Blisce US LLC. The holdings identified on this page are intended to represent the current and historical investments of the Blisce Group and its partners. As such, these holdings may not represent all of the investments that have previously been purchased or sold by the Blisce Group. Furthermore, these holdings include without distinction both the proprietary investments of the Blisce Group and investments on behalf of its clients. It should not be assumed that recommendations made or investment opportunities available to clients in the future will be commensurate or profitable or otherwise will equal the performance of the holdings identified on this page.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2021 | Wecasa | Series A | 17.8M |
2/2020 | Headspace Health | Series C | 0 |
1/2023 | Welcome to the Jungle | Series C | 0 |
6/2015 | Teads US | Secondary Market | - |
1/2021 | Too Good To Go | Venture Round | 0 |
10/2013 | Series E | 225M | |
6/2017 | All Turtles | Venture Round | - |
10/2015 | CaaStle | Series A | - |
7/2022 | Too Good To Go | Venture Round | - |
1/2016 | Spotify | Secondary Market | - |
5/2014 | Series F | 200M | |
6/2018 | Candid | Convertible Note | 8M |
7/2018 | Hubble Contacts | Series B | 0 |
1/2021 | Too Good To Go | Venture Round | 0 |
10/2019 | Brut | Series B | 0 |
12/2016 | Teads US | Secondary Market | - |
1/2017 | Adore Me | Secondary Market | - |
7/2022 | Talkiatry | Series B | - |
7/2016 | Spotify | Secondary Market | - |
12/2017 | Harry&s;s | Series D | 112.6M |
8/2019 | DICE | Series B | - |
11/2014 | Spotify | Secondary Market | - |
8/2022 | Imperfect Foods | Convertible Note | - |
9/2021 | Sorare | Series B | 0 |
3/2020 | Music World Media | Series B | 55.9M |
12/2016 | Managed by Q | Series C | 30M |
9/2021 | DICE | Series C | 0 |
1/2021 | Too Good To Go Denmark | Venture Round | 31.1M |
3/2021 | Redesign Health | Equity | 250M |
1/2018 | Stadium Goods | Convertible Note | 11.5M |
7/2021 | Empower | Series B | - |
9/2014 | Placemeter | Series A | 6M |
3/2021 | Forward | Series D | 0 |
12/2020 | Too Good To Go | Series B | - |
6/2015 | Secondary Market | - | |
2/2021 | Imperfect Foods | Series D | 0 |
9/2015 | BlaBlaCar | Series D | 200M |
4/2014 | Alibaba Group | Secondary Market | 100M |
4/2018 | Knotel | Series B | 0 |
6/2018 | MYCS | Series B | 0 |
6/2015 | Harry&s;s | Series C | 97.5M |
6/2016 | Placemeter | Venture Round | 1.6M |
11/2014 | Kik | Series C | 38.3M |
4/2019 | Candid | Series B | 63.4M |
6/2020 | Headspace Health | Series C | 0 |
9/2021 | Dapper Labs | Series D | 0 |
11/2017 | LE TOTE | Series C | 9.5M |
2/2013 | Series D | 200M | |
6/2018 | Bird | Series C | 0 |
9/2021 | DICE | Series C | 0 |
9/2021 | Dapper Labs | Series D | 0 |
9/2021 | Sorare | Series B | 0 |
7/2021 | Empower | Series B | - |
7/2021 | Wecasa | Series A | 0 |
3/2021 | Redesign Health | Venture Round | 0 |
3/2021 | Forward | Series D | 0 |
2/2021 | Imperfect Foods | Series D | 0 |
1/2021 | Too Good To Go | Venture Round | 0 |
1/2021 | Too Good To Go | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|